U.S. Physical Therapy, Inc. USPH
$83.08
-$0.31-0.37%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.93% | 7.71% | 13.31% | 17.85% | 17.06% |
| Total Other Revenue | 6.36% | 8.70% | 8.77% | 14.61% | 23.19% |
| Total Revenue | 8.49% | 7.88% | 12.54% | 17.28% | 18.05% |
| Cost of Revenue | 11.12% | 8.85% | 11.60% | 17.86% | 16.77% |
| Gross Profit | 0.29% | 4.06% | 15.97% | 15.26% | 22.24% |
| SG&A Expenses | 7.16% | 12.49% | 16.40% | 21.06% | 20.28% |
| Depreciation & Amortization | -2.09% | 2.13% | -22.51% | 32.15% | 33.54% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.28% | 8.99% | 10.90% | 18.57% | 17.61% |
| Operating Income | -3.96% | -4.33% | 27.94% | 6.81% | 21.22% |
| Income Before Tax | -15.89% | -39.04% | -18.37% | 85.43% | 53.11% |
| Income Tax Expenses | -15.77% | -37.64% | -0.79% | 104.49% | 60.01% |
| Earnings from Continuing Operations | -15.93% | -39.44% | -26.56% | 80.44% | 51.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.14% | 12.64% | -54.52% | -43.03% | -26.65% |
| Net Income | -20.13% | -49.11% | -55.07% | 98.22% | 65.11% |
| EBIT | -3.96% | -4.33% | 27.94% | 6.81% | 21.22% |
| EBITDA | -3.57% | -2.48% | 16.41% | 11.89% | 23.58% |
| EPS Basic | -56.45% | -115.26% | -182.45% | 23.61% | 24.12% |
| Normalized Basic EPS | -6.00% | 4.53% | 13.37% | -23.40% | 6.88% |
| EPS Diluted | -56.45% | -115.26% | -182.45% | 23.61% | 24.12% |
| Normalized Diluted EPS | -6.00% | 4.53% | 13.37% | -23.40% | 6.88% |
| Average Basic Shares Outstanding | -0.84% | 0.23% | 0.52% | 0.84% | 0.83% |
| Average Diluted Shares Outstanding | -0.84% | 0.23% | 0.52% | 0.84% | 0.83% |
| Dividend Per Share | 2.22% | 2.22% | 2.27% | 2.27% | 2.27% |
| Payout Ratio | 0.27% | -- | 1.29% | -0.48% | -0.38% |